| Name | Title | Contact Details |
|---|
RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.
Capital City Nurses is a Chevy Chase, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
To the scientific community, the name Harlan has meant high quality animals for over 70 years. Howard P. Harlan foresaw the need for laboratory animals and founded the business in Indianapolis, Indiana, in 1931. From 1931 until the time of his death in
BodyMedia is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Pittsburgh, PA. To find more information about BodyMedia, please visit www.bodymedia.com
Gallus Biopharmaceuticals is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.